Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Merrick

Concepts (309)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
41
2024
2340
3.040
Why?
Precancerous Conditions
12
2024
160
2.510
Why?
Carcinoma, Squamous Cell
15
2024
625
2.010
Why?
Carcinoma, Non-Small-Cell Lung
13
2023
1049
1.350
Why?
Adenocarcinoma
7
2019
891
0.640
Why?
Bronchi
6
2018
247
0.470
Why?
Chemoprevention
4
2019
91
0.450
Why?
Biopsy
8
2023
1084
0.420
Why?
ErbB Receptors
6
2023
602
0.400
Why?
Disease Progression
7
2019
2622
0.400
Why?
Biomarkers, Tumor
8
2018
1161
0.390
Why?
Carmustine
3
2020
50
0.390
Why?
Heat-Shock Proteins
1
2012
136
0.370
Why?
Neovascularization, Pathologic
5
2015
295
0.370
Why?
Bronchial Neoplasms
2
2011
14
0.350
Why?
Papillomaviridae
4
1996
113
0.340
Why?
Polymorphism, Genetic
1
2012
637
0.310
Why?
Lung Diseases
1
2015
739
0.310
Why?
Smoke
3
2020
139
0.310
Why?
Keratinocytes
4
1996
242
0.310
Why?
Proto-Oncogene Proteins
3
2018
635
0.300
Why?
Cell Transformation, Neoplastic
4
2024
326
0.300
Why?
Lung
10
2025
3926
0.300
Why?
Smoking
6
2019
1499
0.300
Why?
Gene Dosage
3
2016
143
0.290
Why?
Formaldehyde
2
2025
60
0.280
Why?
Carcinogenesis
2
2020
213
0.280
Why?
Inflammation
1
2018
2735
0.280
Why?
Gene Expression Regulation, Neoplastic
6
2018
1336
0.270
Why?
B7-H1 Antigen
2
2019
195
0.270
Why?
Epoprostenol
2
2018
136
0.260
Why?
Iloprost
4
2018
45
0.260
Why?
Carcinogens
5
2018
110
0.260
Why?
Mice
22
2025
16905
0.240
Why?
In Situ Hybridization, Fluorescence
3
2018
312
0.230
Why?
Humans
51
2024
129143
0.230
Why?
Mutation
6
2023
3705
0.230
Why?
Sputum
4
2019
301
0.220
Why?
Mast Cells
1
2025
142
0.220
Why?
Receptor, ErbB-2
1
2006
325
0.220
Why?
Immunohistochemistry
5
2015
1678
0.210
Why?
Cardiomyopathy, Hypertrophic, Familial
1
2003
16
0.210
Why?
Neoplasm Invasiveness
4
2015
481
0.200
Why?
Chest Pain
1
2003
88
0.200
Why?
Desmoglein 3
2
2022
15
0.200
Why?
Lidocaine
1
2022
41
0.200
Why?
Cell Proliferation
4
2018
2368
0.200
Why?
Gelatin
1
2022
42
0.200
Why?
Vascular Endothelial Growth Factor A
1
2005
529
0.190
Why?
Epithelial-Mesenchymal Transition
3
2022
201
0.190
Why?
Neuropilin-1
1
2021
9
0.190
Why?
Inflammation Mediators
1
2025
504
0.190
Why?
Male
29
2025
63455
0.190
Why?
Ki-67 Antigen
2
2015
108
0.180
Why?
Animals
23
2025
35286
0.180
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
84
0.180
Why?
Female
29
2022
68493
0.180
Why?
Middle Aged
18
2020
31049
0.180
Why?
Cysts
1
2021
108
0.170
Why?
Receptor, IGF Type 1
2
2010
64
0.170
Why?
Air Pollution
1
2023
216
0.170
Why?
Aged
13
2019
21996
0.170
Why?
Disease Models, Animal
5
2020
4056
0.160
Why?
Granulomatosis with Polyangiitis
1
2020
42
0.160
Why?
Cell Cycle Proteins
2
2018
584
0.160
Why?
Carcinoma in Situ
1
2019
45
0.160
Why?
Respiratory System
1
2020
154
0.160
Why?
Pneumonia
1
2025
616
0.160
Why?
Drug Resistance, Neoplasm
3
2023
751
0.160
Why?
Air Pollutants
1
2023
312
0.160
Why?
Gene Expression Profiling
2
2005
1683
0.150
Why?
gamma Catenin
1
2018
13
0.150
Why?
Fluorescent Antibody Technique
1
2019
375
0.150
Why?
Exons
1
2020
341
0.150
Why?
Metaplasia
1
2018
54
0.150
Why?
Bronchial Diseases
1
2018
37
0.150
Why?
Mucin 5AC
1
2018
69
0.150
Why?
MicroRNAs
2
2016
676
0.140
Why?
Cell Cycle Checkpoints
1
2018
95
0.140
Why?
Protein Kinase Inhibitors
3
2023
885
0.140
Why?
Anticarcinogenic Agents
1
2018
77
0.140
Why?
Tobacco Smoke Pollution
1
2020
231
0.140
Why?
Aged, 80 and over
7
2017
7037
0.140
Why?
RNA, Messenger
5
2022
2699
0.140
Why?
Urethane
4
2023
41
0.130
Why?
Cell Transformation, Viral
2
1993
27
0.130
Why?
Head and Neck Neoplasms
1
2021
542
0.130
Why?
Frizzled Receptors
1
2016
23
0.130
Why?
Antigen Presentation
1
2017
207
0.130
Why?
Oncogene Proteins, Fusion
1
2018
200
0.130
Why?
Myocardial Infarction
1
2003
1021
0.130
Why?
Oncogenes
1
2016
110
0.120
Why?
Porphyrins
1
2015
21
0.120
Why?
Tomography, Spiral Computed
1
2015
27
0.120
Why?
Proto-Oncogene Proteins c-met
1
2016
74
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
204
0.120
Why?
Topoisomerase Inhibitors
1
2015
4
0.120
Why?
Smad4 Protein
1
2015
38
0.120
Why?
Protein-Tyrosine Kinases
1
2018
431
0.110
Why?
Adult
11
2018
35469
0.110
Why?
Neoplasms
2
2024
2442
0.110
Why?
Bronchopulmonary Dysplasia
1
2019
378
0.110
Why?
Chromosomal Instability
1
2013
18
0.110
Why?
Macrophages, Alveolar
2
2023
389
0.110
Why?
Mice, Transgenic
5
2018
2117
0.110
Why?
Microarray Analysis
1
2013
116
0.110
Why?
Stem Cells
1
2018
574
0.110
Why?
Neoplasms, Basal Cell
1
2013
3
0.110
Why?
Trachea
1
2015
220
0.110
Why?
Endoscopy
1
2015
285
0.100
Why?
Interleukin-1
1
1996
959
0.100
Why?
Tretinoin
1
1993
130
0.100
Why?
Quinazolines
2
2012
243
0.100
Why?
Prognosis
5
2020
3766
0.100
Why?
Piperidines
2
2012
198
0.100
Why?
B-Lymphocytes
1
2017
815
0.100
Why?
Receptors, Transforming Growth Factor beta
1
2012
56
0.090
Why?
PTEN Phosphohydrolase
1
2013
161
0.090
Why?
Antigens, Differentiation
1
1992
81
0.090
Why?
Cohort Studies
3
2023
5408
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1554
0.090
Why?
Early Detection of Cancer
1
2015
369
0.090
Why?
CD4-Positive T-Lymphocytes
1
2017
1056
0.090
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2012
946
0.090
Why?
Cell Line
4
2019
2775
0.090
Why?
Hyperplasia
1
2011
171
0.090
Why?
Tissue Array Analysis
3
2019
55
0.090
Why?
Diagnosis, Differential
3
2021
1429
0.090
Why?
Epithelium
4
2018
311
0.090
Why?
Receptor Protein-Tyrosine Kinases
1
2012
231
0.090
Why?
Pulmonary Surgical Procedures
1
2010
8
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
983
0.080
Why?
Nuclear Proteins
3
2006
658
0.080
Why?
Small Cell Lung Carcinoma
1
2010
88
0.080
Why?
Pulmonary Alveoli
1
2012
400
0.080
Why?
Vasodilator Agents
1
2011
326
0.080
Why?
Cell Polarity
1
2010
139
0.080
Why?
Enzyme-Linked Immunosorbent Assay
2
2005
832
0.080
Why?
Neoplasm Staging
3
2020
1280
0.080
Why?
Follow-Up Studies
2
2015
4882
0.080
Why?
Epithelial Cells
4
2018
1064
0.080
Why?
Receptors, Fibroblast Growth Factor
1
2008
65
0.070
Why?
Solitary Fibrous Tumor, Pleural
1
2008
4
0.070
Why?
Osteoarthropathy, Secondary Hypertrophic
1
2008
4
0.070
Why?
Echocardiography
2
2003
629
0.070
Why?
Smokers
2
2019
138
0.070
Why?
Neoplasms, Experimental
2
2018
170
0.070
Why?
Fibroblast Growth Factors
1
2008
169
0.070
Why?
Carcinoma, Small Cell
1
2008
169
0.070
Why?
Edema
1
2008
124
0.070
Why?
Monocytes
1
2010
551
0.070
Why?
Genome-Wide Association Study
1
2013
1326
0.070
Why?
Radiography, Thoracic
1
2008
166
0.070
Why?
Gene Expression Regulation
1
2016
2536
0.070
Why?
Bronchoalveolar Lavage Fluid
2
2025
644
0.070
Why?
Mice, Inbred C57BL
3
2025
5438
0.070
Why?
Minichromosome Maintenance Complex Component 2
1
2006
4
0.060
Why?
Hydrogels
2
2023
629
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2059
0.060
Why?
Placebos
2
2019
201
0.060
Why?
Treatment Outcome
5
2022
10192
0.060
Why?
Prevalence
2
2023
2554
0.060
Why?
Biomarkers
4
2023
3963
0.060
Why?
Tumor Microenvironment
2
2021
627
0.060
Why?
Transcription Factors
1
1993
1644
0.060
Why?
Cell Movement
2
2025
944
0.060
Why?
Mice, Inbred A
2
2020
48
0.060
Why?
Chromosome Aberrations
2
2017
147
0.060
Why?
Hypoxia
1
2012
1084
0.060
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
107
0.060
Why?
Bronchoscopy
2
2019
215
0.060
Why?
Proto-Oncogene Proteins p21(ras)
2
2018
259
0.060
Why?
Prospective Studies
4
2023
7117
0.060
Why?
Japan
1
2003
98
0.050
Why?
Gene Knockdown Techniques
2
2015
316
0.050
Why?
Keratin-5
1
2022
50
0.050
Why?
Diagnostic Errors
1
2003
162
0.050
Why?
Aniline Compounds
1
2023
97
0.050
Why?
Alveolar Epithelial Cells
1
2023
106
0.050
Why?
Signal Transduction
3
2012
4919
0.050
Why?
Up-Regulation
1
2005
838
0.050
Why?
Particle Size
1
2023
351
0.050
Why?
Dendritic Cells
1
2025
479
0.050
Why?
Molecular Targeted Therapy
2
2018
390
0.050
Why?
Adaptive Immunity
1
2023
161
0.050
Why?
Immunoenzyme Techniques
2
2012
212
0.050
Why?
Mice, Inbred BALB C
2
2011
1246
0.050
Why?
Interferon-gamma
2
2018
772
0.050
Why?
Sensitivity and Specificity
1
2006
1833
0.050
Why?
PPAR gamma
1
2022
183
0.050
Why?
Tubulin
1
2022
137
0.050
Why?
Double-Blind Method
2
2019
1874
0.040
Why?
Incidence
2
2008
2635
0.040
Why?
Particulate Matter
1
2023
246
0.040
Why?
Acute Disease
1
2003
978
0.040
Why?
Pain, Postoperative
1
2022
233
0.040
Why?
Oximes
1
2020
22
0.040
Why?
Exercise Test
1
2003
612
0.040
Why?
Electrocardiography
1
2003
608
0.040
Why?
Blotting, Western
2
2012
1202
0.040
Why?
Pyrimidinones
1
2020
102
0.040
Why?
Rituximab
1
2020
164
0.040
Why?
Amino Acid Substitution
1
2020
282
0.040
Why?
Cell Line, Transformed
2
1996
141
0.040
Why?
Environmental Exposure
1
2023
462
0.040
Why?
Breast Neoplasms
1
2011
2127
0.040
Why?
Imidazoles
1
2020
234
0.040
Why?
T-Lymphocytes, Regulatory
1
2021
373
0.040
Why?
Remission Induction
1
2019
271
0.040
Why?
RNA
1
2005
880
0.040
Why?
Diagnostic Imaging
1
2021
325
0.040
Why?
Pyridones
1
2020
158
0.040
Why?
Tobacco Smoking
1
2018
25
0.040
Why?
Intramolecular Oxidoreductases
1
2018
67
0.040
Why?
Tricuspid Valve
1
1998
27
0.040
Why?
Mass Screening
2
2004
1148
0.040
Why?
Time
1
2018
75
0.040
Why?
RNA, Small Interfering
2
2012
591
0.040
Why?
Proto-Oncogene Proteins B-raf
1
2020
209
0.040
Why?
Risk Factors
3
2019
9740
0.040
Why?
Ventricular Outflow Obstruction
1
1998
40
0.040
Why?
Cytochrome P-450 Enzyme System
1
2018
151
0.040
Why?
Tumor Burden
1
2018
286
0.030
Why?
Lymphocyte Count
1
2017
148
0.030
Why?
Immunotherapy
1
2021
590
0.030
Why?
Antigen-Presenting Cells
1
2017
151
0.030
Why?
Carcinogenicity Tests
1
1996
6
0.030
Why?
DNA Copy Number Variations
1
2018
168
0.030
Why?
Structure-Activity Relationship
1
2018
543
0.030
Why?
Blotting, Northern
1
1996
201
0.030
Why?
Neoplasms, Glandular and Epithelial
1
1996
35
0.030
Why?
Cells, Cultured
2
2016
4075
0.030
Why?
Neoplasm Transplantation
1
1996
256
0.030
Why?
Immunophenotyping
1
2017
310
0.030
Why?
Centrosome
1
2016
64
0.030
Why?
Plasmids
1
1996
358
0.030
Why?
Mitotic Index
1
2015
26
0.030
Why?
Smoking Cessation
1
2019
405
0.030
Why?
Survival Analysis
1
2018
1268
0.030
Why?
Cell Differentiation
2
1993
1888
0.030
Why?
Mice, Nude
1
1996
682
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2018
485
0.030
Why?
Phenotype
2
1993
3071
0.030
Why?
Neoplasm Grading
1
2015
282
0.030
Why?
Uterine Cervical Neoplasms
1
1996
229
0.030
Why?
Loss of Heterozygosity
1
2013
46
0.030
Why?
Retinoid X Receptors
1
1993
41
0.030
Why?
Computational Biology
1
2018
596
0.030
Why?
Receptors, Retinoic Acid
1
1993
51
0.030
Why?
DNA Repair
1
2015
206
0.030
Why?
Lymphocyte Activation
1
2017
1109
0.030
Why?
Organ Culture Techniques
1
1993
153
0.030
Why?
Drug Resistance
1
1993
165
0.030
Why?
Cytosol
1
1993
219
0.030
Why?
Models, Molecular
1
2018
1485
0.030
Why?
Macrophages
1
2020
1481
0.030
Why?
Cell Line, Tumor
2
2012
3186
0.030
Why?
Methylcholanthrene
1
2012
22
0.020
Why?
c-Mer Tyrosine Kinase
1
2012
44
0.020
Why?
Respiratory Mucosa
1
2015
307
0.020
Why?
Butylated Hydroxytoluene
1
2012
38
0.020
Why?
Immunoprecipitation
1
2012
157
0.020
Why?
Proliferating Cell Nuclear Antigen
1
1992
53
0.020
Why?
Intermediate Filament Proteins
1
1992
57
0.020
Why?
Receptors, Cytoplasmic and Nuclear
1
1993
217
0.020
Why?
United States
2
2011
13825
0.020
Why?
Gene Deletion
1
2013
380
0.020
Why?
Administration, Topical
1
2011
145
0.020
Why?
Sleep Apnea Syndromes
1
2012
82
0.020
Why?
Keratins
1
1992
175
0.020
Why?
Mutation, Missense
1
2013
317
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2012
131
0.020
Why?
Antineoplastic Agents
2
2012
2045
0.020
Why?
Administration, Oral
1
2012
785
0.020
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
235
0.020
Why?
Carcinoma, Large Cell
1
2010
15
0.020
Why?
RNA Interference
1
2012
449
0.020
Why?
Severity of Illness Index
1
2018
2736
0.020
Why?
Cell Division
1
1992
796
0.020
Why?
Aneuploidy
1
2010
92
0.020
Why?
Xenograft Model Antitumor Assays
1
2012
808
0.020
Why?
Mice, Inbred Strains
1
2010
406
0.020
Why?
Interleukin-4
1
2010
212
0.020
Why?
Antioxidants
1
2012
558
0.020
Why?
Disease-Free Survival
1
2010
644
0.020
Why?
Kaplan-Meier Estimate
1
2010
851
0.020
Why?
Survival Rate
1
2011
1869
0.020
Why?
Cross-Sectional Studies
1
2018
5044
0.020
Why?
Proportional Hazards Models
1
2010
1197
0.020
Why?
Skin
1
1991
726
0.020
Why?
Dose-Response Relationship, Drug
1
2010
2008
0.020
Why?
Databases, Nucleic Acid
1
2005
33
0.020
Why?
Enzymes
1
2005
65
0.020
Why?
Case-Control Studies
1
2012
3372
0.010
Why?
Species Specificity
1
2005
574
0.010
Why?
Cluster Analysis
1
2005
480
0.010
Why?
Cytokines
1
2012
2012
0.010
Why?
DNA Replication
1
2005
227
0.010
Why?
Age Factors
1
2011
3140
0.010
Why?
Antibodies, Monoclonal
1
2010
1363
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2005
755
0.010
Why?
Apoptosis
1
2012
2491
0.010
Why?
Young Adult
1
2018
12385
0.010
Why?
Risk Assessment
1
2010
3231
0.010
Why?
Time Factors
1
2010
6541
0.010
Why?
Retrospective Studies
1
2016
14450
0.010
Why?
Echocardiography, Transesophageal
1
1998
91
0.010
Why?
Culture Techniques
1
1991
81
0.010
Why?
Reference Values
1
1991
793
0.000
Why?
Merrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)